Company
Business
Stem Cell Therapy
Organoid
CDMO Business
| Date | Title | Presentation Obligator |
|---|---|---|
|
20 2026.07 |
Extension of overheated short-selling issue designation (subject to extension of restriction on short-selling) | KOSDAQ STOCK MKT. |
|
16 2026.07 |
Designation of overheated short-selling issues (applied by a restriction on short-selling) | KOSDAQ STOCK MKT. |
|
15 2026.07 |
Material Management Information related to Judgment of Investment(기술도입 계약 체결) | |
|
02 2026.06 |
Organization of Investor Relations Event | |
|
15 2026.04 |
[Investment Caution] The issue excessively purchased by a few accounts in the most recent 15 trading days | |
|
30 2026.03 |
Outcomes of Annual Meeting of Shareholders | |
|
20 2026.03 |
Submission of Audit Report | |
|
12 2026.03 |
Resolutions for Convocation of General Meeting of Shareholders | |
|
12 2026.03 |
Reporting reasons for holding general shareholders' meeting on the most concentrated date | |
|
12 2026.03 |
[Revised]30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) |